4780 Organometallics, Vol. 24, No. 20, 2005
Table 2. Crystal Data and Experimental Details
3a 4a 5a
18H18NRh C22H26NRh
Kohl et al.
6a
C22H26IrN
empirical formula
fw
C
C18H18IrN
440.53
351.24
407.35
triclinic
P1h
496.64
triclinic
P1h
cryst syst
monoclinic
monoclinic
P21/n
space group
P21/n
unit cell dimens
a, Å
14.5264(8)
6.9596(4)
14.5137(8)
6.9902(4)
7.310(5)
7.2888(1)
11.0309(2)
12.0453(2)
81.382(1)
78.660(1)
72.152(1)
899.69(3)
2
b, Å
11.092(6)
c, Å
27.986(2)
27.8759(15)
90
12.134(7)
R, deg
90
81.36(4)
â, deg
93.454(1)
93.593(1)
78.19(5)
γ, deg
90
90
72.32(5)
volume, Å3
2824.2(3)
2822.6(3)
913.4(10)
Z
8
8
2
density(calc), g/cm3
F(000)
1.652
2.073
1.481
1.833
484
1424
1680
420
cryst size, mm3
θ range for data collection, deg
index ranges
0.38 × 0.27 × 0.16
1.62 to 32.02
-21 e h e 21,
0 e k e 10,
0 e l e 41
47 841
0.36 × 0.10 × 0.07
1.54 to 32.04
-18 e h e 21,
-10 e k e 10,
-38 e l e 41
24 556
0.10 × 0.17 × 0.35
1.72 to 25.06
-8 e h e 8,
-12 e k e 13,
0 e l e 14
3226
0.51 × 0.44 × 0.10
1.73 to 28.29
-9 e h e 9,
-14 e k e 14,
-16 e l e 15
11 993
no. of reflns collected
no. of indep reflns
9719 [R(int) ) 0.0284]
9719/0/505
1.341
R1 ) 0.0394,
wR2 ) 0.0857
R1 ) 0.0409,
wR2 ) 0.0862
2.183 and -1.953
9540 [R(int) ) 0.0304]
9540/0/426
1.156
R1 ) 0.0408,
wR2 ) 0.0825
R1 ) 0.0471,
wR2 ) 0.0846
4.048 and -3.618
3226 [R(int) ) 0.0000]
3226/0/278
1.063
R1 ) 0.0453,
wR2 ) 0.1014
R1 ) 0.0728,
wR2 ) 0.1096
0.571 and -0.504
4392 [R(int) ) 0.0446]
4392/0/316
no. of data/restraints/params
goodness-of-fit on F2
1.115
final R indices [I > 2σ(I)]
R1 ) 0.0372,
wR2 ) 0.0989
R1 ) 0.0379,
wR2 ) 0.0995
2.337 and -3.856
R indices (all data)
largest diff peak and hole, e Å-3
temperature overnight. The solvents were evaporated. Column
chromatography on Al2O3/5% H2O using toluene as eluent
yielded 270 mg (0.61 mmol, 56%) of 4a as a dark yellow solid.
1H NMR (CDCl3): δ 0.67-0.77 (m, 4H, ethene-CH2); 2.35-
2.45 (m, 4H, ethene-CH2); 5.32 (pt, 2H, Cp-CH); 6.35 (pt, 2H,
Cp-CH); 7.35 (dd, 3J(H3,H2) ) 4.1 Hz, 3J(H3,H4) ) 8.2 Hz, 1H,
1.72 (br, 4H, ethene-CH2); 1.77 (d, 3J(Rh,H) ) 0.5 Hz, 6H, CH3);
2.13-2.19 (br, 4H, ethene-CH2); 6.73 (dd, 3J(H3,H2) ) 4.0 Hz,
3J(H3,H4) ) 8.2 Hz, 1H, H3); 7.37 (dd, 3J(H,H) ) 6.6 Hz,
3J(H,H) ) 8.2 Hz, 1H, H6); 7.45 (dd, 3J(H,H) ) 8.2 Hz, 4J(H,H)
) 2.0 Hz, 1H, H5 or H7); 7.58 (dd, 3J(H,4H3) ) 8.3 Hz, 4J(H4,H2)
3
4
) 1.9 Hz, 1H, H4); 8.63 (dd, J(H,H) ) 6.6 Hz, J(H,H) ) 1.9
3
3
H3); 7.47 (dd, J(H,H) ) 8.0 Hz, J(H,H) ) 7.3 Hz, 1H, H6);
3
4
Hz, 1H, H5 or H7); 8.65 (dd, J(H2,H3) ) 4.0 Hz, J(H2,H4) )
3
4
7.67 (dd, J(H,H) ) 8.2 Hz, J(H,H) ) 1.5 Hz, 1H, H5 or H7);
1.9 Hz, 1H, H2). 13C NMR (CDCl3): δ 8.9, 10.2 (CH3); 44.8 (d,
3
4
7.73 (dd, J(H,H) ) 7.2 Hz, J(H,H) ) 1.5 Hz, 1H, H5 or H7);
8.10 (dd, 3J(H,4H3) ) 8.3 Hz, 4J(H,4H2) ) 1.8 Hz, 1H, H4); 8.91
(dd, 3J(H2,H3) ) 4.1 Hz, 4J(H2,H4) ) 1.8 Hz, 1H, H2). 13C NMR
(CDCl3): δ 20.1 (ethene-CH2); 81.9, 84.6 (Cp-CH); 100.3 (quart.
Cp-C); 121.0, 126.2, 127.1, 128.7, 136.2, 149.4 (quinoline-CH);
128.7, 131.5, 145.8 (quart. Cquinoline). MS (EI): m/z (%) 413 (54)
[M+ - C2H4]; 385 (100) [M+ - 2 C2H4]; 359 (22) [M+ - 2 C2H4
- C2H2]; 192.5 (18) [M2+ - 2 C2H4]. HR-MS (EI): calcd for
C16H14N193Ir 413.0756; found 413.0751. Anal. Calcd for C18H18-
NIr (440.57): C 49.07, H 4.12, N 3.18. Found: C 49.27, H 4.30,
N 3.31.
1J(Rh,C) ) 13.7 Hz, C2H4); 97.8 (d, J(Rh,C) ) 3.8 Hz, quart.
1
C
Cp); 98.3 (d, 1J(Rh,C) ) 3.8 Hz, quart. CCp); 106.5 (d, 1J(Rh,C)
) 4.6 Hz, quart. CCp); 120.5 126.2, 127.4, 136.1, 138.0, 149.9
(quinoline-CH); 128.3, 134.0, 147.9 (quart. Cquinoline). MS (EI):
m/z (%) 407 (6) [M+]; 379 (15) [M+ - C2H4]; 351 (100) [M+ - 2
C2H4]; 175.5 (9) [M2+ - 2 C2H4]; 103 (5) [Rh+]. Anal. Calcd for
C22H26NRh (407.37): C 64.87, H 6.43, N 3.44. Found: C 65.21,
H 6.38, N 3.33.
Bis(η2-ethene)[η5-2,3,4,5-tetramethyl-1-(8-quinolyl)cy-
clopentadienyl]iridium(I) (6a). To a suspension of 37 mg
(0.92 mmol) of potassium hydride in 25 mL of thf was added
233 mg (0.93 mmol) of 2,3,4,5-tetramethyl-1-(8-quinolyl)-
cyclopentadiene (2H). After stirring for 3 h at room temper-
ature the violet suspension was added to a solution of 265 mg
(0.47 mmol) of di-µ-chlorotetrakis(ethene)diiridium(I) in 25 mL
of toluene, which was kept at -78 °C. The resulting mixture
was warmed to room temperature overnight. The solvents were
evaporated. Column chromatography on Al2O3/5% H2O using
toluene as eluent yielded 205 mg (0.41 mmol, 45%) of 6a as a
dark yellow solid. 1H NMR (CDCl3): δ 0.88-0.98 (m, 4H,
ethene-CH2); 1.35 (s, 6H, CH3); 1.58-1.68 (m, 4H, ethene-CH2);
Bis(η2-ethene)[η5-2,3,4,5-tetramethyl-1-(8-quinolyl)cy-
clopentadienyl]rhodium(I) (5a). To a suspension of 103 mg
(2.6 mmol) of potassium hydride in 25 mL of thf was added
641 mg (2.3 mmol) of 2,3,4,5-tetramethyl-1-(8-quinolyl)cyclo-
pentadiene (2H). After stirring for 3 h at room temperature
the violet suspension was transferred to a solution of 500 mg
(1.3 mmol) of di-µ-chlorotetrakis(ethene)dirhodium(I) in 25 mL
of toluene via cannula. The resulting brown solution was
stirred overnight. The solvents were evaporated and the
residue suspended in toluene. The precipitated inorganic salts
were separated by filtration with a reversal frit (G4), and the
dark filtrate was chromatographed on Al2O3/5% H2O with
toluene as eluent to give 870 mg (2.14 mmol, 83%) of 5a as a
yellow solid. 1H NMR (CDCl3): δ 1.32 (s, 6H, CH3); 1.36-1.47
(br, 4H, ethene-CH2); 1.90-1.97 (br, 4H, ethene-CH2); 1.98 (d,
3J(Rh,H) ) 0.5 Hz, 6H, CH3); 7.33 (dd, 3J(H3,H2) ) 4.2 Hz,
3J(H3,H4) ) 8.1 Hz, 1H, H3); 7.55 (dd, 3J(H,H) ) 7.1 Hz,
3J(H,H) ) 8.1 Hz, 1H, H6); 7.77 (dd, 3J(H,H) ) 8.1 Hz, 4J(H,H)
) 1.5 Hz, 1H, H5 or H7); 8.15 (dd, 3J(H,4H3) ) 8.1 Hz, 4J(H4,H2)
3
3
2.03 (s, 6H, CH3); 7.34 (dd, J(H3,H2) ) 4.2 Hz, J(H3,H4) )
8.3 Hz, 1H, H3); 7.47-7.58 (m, 1H, H6); 7.79 (dd, J(H,H) )
3
8.2 Hz, J(H,H) ) 1.2 Hz, 1H, H5 or H7); 8.15 (dd, J(H,H) )
4
3
8.2 Hz, J(H,H) ) 1.6 Hz, 1H, H4); 8.26 (dd, J(H,4H3) ) 7.1
4
3
Hz, J(H,4H2) ) 1.2 Hz, 1H, H5 or H7); 8.91 (dd, J(H2,H3) )
4.2 Hz, 4J(H2,H4) ) 1.6 Hz, 1H, H2). 13C NMR (CDCl3): δ 8.2,
10.1 (Cp-CH3); 24.9 (ethene-CH2); 93.8, 95.0, 100.4 (quart. CCp);
120.6, 126.5, 127.8, 136.1, 139.4, 150.1 (quinoline-CH); 128.2,
132.9, 147.3 (quart. Cquinoline). MS (EI): m/z (%) 497 (6) [M+],
469 (63) [M+ - C2H4], 441 (100) [M+ - 2 C2H4], 249 (54) [M+
- 2 C2H4 - Ir], 234 (69) [M+ - 2 C2H4 - Ir - CH3]. Anal.
4
3
3
4
) 1.7 Hz, 1H, H4); 8.42 (dd, J(H,H) ) 7.1 Hz, J(H,H) ) 1.5
3
4
Hz, 1H, H5 or H7); 8.91 (dd, J(H2,H3) ) 4.2 Hz, J(H2,H4) )
1.7 Hz, 1H, H2). H NMR (C6D6): δ 1.32 (s, 6H, CH3); 1.66-
1